71 related articles for article (PubMed ID: 22035050)
1. Effects of titanium surface anodization with CaP incorporation on human osteoblastic response.
Oliveira NC; Moura CC; Zanetta-Barbosa D; Mendonça DB; Cooper L; Mendonça G; Dechichi P
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1958-62. PubMed ID: 23498218
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Anticoagulants on Early Implant Failure: A Retrospective Cohort Study.
Chaushu L; Perez N; Botticelli D; Xavier SP; Kolerman R; Masri D
J Funct Biomater; 2023 Mar; 14(4):. PubMed ID: 37103275
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial.
Song R; Qu R; Wang Y; Zhou D; Zhang A
Medicine (Baltimore); 2021 Jan; 100(1):e23814. PubMed ID: 33429741
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulants and Osteoporosis.
Signorelli SS; Scuto S; Marino E; Giusti M; Xourafa A; Gaudio A
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652944
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Effects of Fucoidans on the Cell Viability of Tumor and Non-Tumor Cell Lines.
Bittkau KS; Dörschmann P; Blümel M; Tasdemir D; Roider J; Klettner A; Alban S
Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31357497
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
Monaco L; Biagi C; Conti V; Melis M; Donati M; Venegoni M; Vaccheri A; Motola D
Br J Clin Pharmacol; 2017 Jul; 83(7):1532-1543. PubMed ID: 28071818
[TBL] [Abstract][Full Text] [Related]
7. Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model.
Prodinger PM; Burgkart R; Kreutzer K; Liska F; Pilge H; Schmitt A; Knödler M; Holzapfel BM; Hapfelmeier A; Tischer T; Bissinger O
PLoS One; 2016; 11(7):e0159669. PubMed ID: 27455072
[TBL] [Abstract][Full Text] [Related]
8. Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing.
Pilge H; Fröbel J; Prodinger PM; Mrotzek SJ; Fischer JC; Zilkens C; Bittersohl B; Krauspe R
Bone Joint Res; 2016 Mar; 5(3):95-100. PubMed ID: 26989119
[TBL] [Abstract][Full Text] [Related]
9. Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban.
Pilge H; Fröbel J; Mrotzek SJ; Fischer JC; Prodinger PM; Zilkens C; Bittersohl B; Krauspe R
BMC Musculoskelet Disord; 2016 Mar; 17():108. PubMed ID: 26927834
[TBL] [Abstract][Full Text] [Related]
10. Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis.
Gajic-Veljanoski O; Phua CW; Shah PS; Cheung AM
J Gen Intern Med; 2016 Aug; 31(8):947-57. PubMed ID: 26895998
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis and orthopaedic surgery: options and current guidelines.
Solayar GN; Shannon FJ
Malays J Med Sci; 2014 May; 21(3):71-7. PubMed ID: 25246838
[TBL] [Abstract][Full Text] [Related]
12. Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.
Stöllberger C; Finsterer J
Drugs Aging; 2013 Dec; 30(12):949-58. PubMed ID: 24170233
[TBL] [Abstract][Full Text] [Related]
13. The out-of-focus bias in drug surveillance.
Gnädinger M; Mellinghoff HU
Eur J Clin Pharmacol; 2013 Mar; 69(3):357-9. PubMed ID: 22895799
[TBL] [Abstract][Full Text] [Related]
14. The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.
Solayar GN; Walsh PM; Mulhall KJ
BMC Musculoskelet Disord; 2011 Oct; 12():247. PubMed ID: 22035050
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban, a direct inhibitor of the coagulation factor Xa interferes with hormonal-induced physiological modulations in human female osteoblastic cell line SaSO2.
Somjen D; Katzburg S; Gigi R; Dolkart O; Sharon O; Salai M; Stern N
J Steroid Biochem Mol Biol; 2013 May; 135():67-70. PubMed ID: 23333933
[TBL] [Abstract][Full Text] [Related]
16. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Duggan ST; Scott LJ; Plosker GL
Drugs; 2009; 69(13):1829-51. PubMed ID: 19719335
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
